Literature DB >> 7935445

Ets-1 activates the DRA promoter in B cells.

N Jabrane-Ferrat1, B M Peterlin.   

Abstract

The X box in promoters of class II major histocompatibility complex genes plays a crucial role in the B-cell-specific and gamma interferon-inducible expression of these genes. The sequence TTCC is located in the pyrimidine tract which extends 5' to and partially overlaps the X box of the DRA promoter. This sequence resembles the core binding site for the Ets family of DNA-binding proteins. In this study, we demonstrate that mutations within the pyrimidine tract which change the TTCC motif, but do not affect the binding of regulatory factor X to the X box, decrease the activity of the DRA promoter in B cells. Furthermore, using electrophoretic mobility shift assays and cotransfection experiments, we demonstrate that Ets-1, but not Ets-2 or PU.1, functionally interacts with the pyrimidine tract and activates the DRA promoter.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7935445      PMCID: PMC359266          DOI: 10.1128/mcb.14.11.7314-7321.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence.

Authors:  F D Karim; L D Urness; C S Thummel; M J Klemsz; S R McKercher; A Celada; C Van Beveren; R A Maki; C V Gunther; J A Nye
Journal:  Genes Dev       Date:  1990-09       Impact factor: 11.361

2.  A human beta-actin expression vector system directs high-level accumulation of antisense transcripts.

Authors:  P Gunning; J Leavitt; G Muscat; S Y Ng; L Kedes
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  A beta-cell-specific protein binds to the two major regulatory sequences of the insulin gene enhancer.

Authors:  H Ohlsson; O Karlsson; T Edlund
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

4.  MHC class II regulatory factor RFX has a novel DNA-binding domain and a functionally independent dimerization domain.

Authors:  W Reith; C Herrero-Sanchez; M Kobr; P Silacci; C Berte; E Barras; S Fey; B Mach
Journal:  Genes Dev       Date:  1990-09       Impact factor: 11.361

5.  NF-X2 that binds to the DRA X2-box is activator protein 1. Expression cloning of c-Jun.

Authors:  G Andersson; B M Peterlin
Journal:  J Immunol       Date:  1990-11-15       Impact factor: 5.422

6.  Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X.

Authors:  W Reith; S Satola; C H Sanchez; I Amaldi; B Lisowska-Grospierre; C Griscelli; M R Hadam; B Mach
Journal:  Cell       Date:  1988-06-17       Impact factor: 41.582

7.  Ets proteins: new factors that regulate immunoglobulin heavy-chain gene expression.

Authors:  R R Rivera; M H Stuiver; R Steenbergen; C Murre
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

8.  Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells.

Authors:  J G Sodroski; C A Rosen; W A Haseltine
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

Review 9.  Organ-specific autoimmunity: a 1986 overview.

Authors:  G F Bottazzo; I Todd; R Mirakian; A Belfiore; R Pujol-Borrell
Journal:  Immunol Rev       Date:  1986-12       Impact factor: 12.988

10.  Identification in chickens of an evolutionarily conserved cellular ets-2 gene (c-ets-2) encoding nuclear proteins related to the products of the c-ets proto-oncogene.

Authors:  K E Boulukos; P Pognonec; A Begue; F Galibert; J C Gesquière; D Stéhelin; J Ghysdael
Journal:  EMBO J       Date:  1988-03       Impact factor: 11.598

View more
  7 in total

1.  Self-association of CIITA and its transactivation potential.

Authors:  T J Sisk; S Roys; C H Chang
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex.

Authors:  N Nekrep; N Jabrane-Ferrat; B M Peterlin
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

3.  Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions.

Authors:  N Jabrane-Ferrat; J D Fontes; J M Boss; B M Peterlin
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

4.  The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32.

Authors:  J D Fontes; B Jiang; B M Peterlin
Journal:  Nucleic Acids Res       Date:  1997-06-15       Impact factor: 16.971

Review 5.  Function and regulation of class II transactivator in the immune system.

Authors:  Cheong-Hee Chang; Tania S Gourley; Tyler J Sisk
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

6.  Binding and cooperative interactions between two B cell-specific transcriptional coactivators.

Authors:  J D Fontes; N Jabrane-Ferrat; C R Toth; B M Peterlin
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

7.  Genome-Wide Identification of Target Genes for the Key B Cell Transcription Factor Ets1.

Authors:  Prontip Saelee; Alyssa Kearly; Stephen L Nutt; Lee Ann Garrett-Sinha
Journal:  Front Immunol       Date:  2017-04-07       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.